{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:06:55Z","timestamp":1783498015016,"version":"3.55.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T00:00:00Z","timestamp":1592870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235142","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T18:22:12Z","timestamp":1592936532000},"page":"e0235142","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6731-7569","authenticated-orcid":true,"given":"Martina","family":"Taborelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Sozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Del Zotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Toffolutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Montico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loris","family":"Zanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Serraino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"pone.0235142.ref001","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"DK Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"pone.0235142.ref002","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences","volume":"126","author":"EV Loftus","year":"2004","journal-title":"Gastroenterology"},{"key":"pone.0235142.ref003","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer","volume":"140","author":"TA Ullman","year":"2011","journal-title":"Gastroenterology"},{"key":"pone.0235142.ref004","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"MW Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0235142.ref005","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.mayocp.2015.03.024","article-title":"Effect of medications on risk of cancer in patients with inflammatory bowel diseases: a population-based cohort study from Olmsted county, Minnesota","volume":"90","author":"S Yadav","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"pone.0235142.ref006","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s00535-016-1199-8","article-title":"A population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease","volume":"51","author":"JC Wilson","year":"2016","journal-title":"J Gastroenterol"},{"key":"pone.0235142.ref007","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1097\/MIB.0000000000001240","article-title":"Cancer risk in 2621 Chinese patients with inflammatory bowel disease: a population-based cohort study","volume":"23","author":"J So","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0235142.ref008","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41395-018-0360-9","article-title":"Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors\u2014Results from the Swiss IBD Cohort Study","volume":"114","author":"S Scharl","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"pone.0235142.ref009","first-page":"1","article-title":"Risk of Malignant Cancers in Inflammatory Bowel Disease","author":"SY Loo","year":"2019","journal-title":"J Crohn\u2019s Colitis"},{"key":"pone.0235142.ref010","first-page":"571","article-title":"Malignancies in Patients with Inflammatory Bowel Disease: Results from 20 Years of Follow-up in the IBSEN Study","volume":"11","author":"\u00d8 Hovde","year":"2017","journal-title":"J Crohn\u2019 s Colitis"},{"key":"pone.0235142.ref011","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ijc.30183","article-title":"Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort","volume":"139","author":"TRA van den Heuvel","year":"2016","journal-title":"Int J Cancer"},{"issue":"10218","key":"pone.0235142.ref012","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study","volume":"395","author":"O Ol\u00e9n","year":"2020","journal-title":"Lancet"},{"key":"pone.0235142.ref013","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/ecco-jcc\/jjx040","article-title":"Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study","volume":"11","author":"YS Jung","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"key":"pone.0235142.ref014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.crohns.2013.04.009","article-title":"Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (II)","volume":"8","author":"L Egan","year":"2014","journal-title":"J Crohn\u2019s Colitis"},{"key":"pone.0235142.ref015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.crohns.2013.04.008","article-title":"Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I).","volume":"8","author":"S Sebastian","year":"2014","journal-title":"J Crohn\u2019s Colitis"},{"key":"pone.0235142.ref016","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/ajg.2009.760","article-title":"Risk of extra-intestinal cancer in inflammatory bowel disease: Meta-analysis of population-based cohort studies","volume":"105","author":"N Pedersen","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"pone.0235142.ref017","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ecco-jcc\/jjv032","article-title":"Incidence, management, and course of cancer in patients with inflammatory bowel disease","volume":"9","author":"A Algaba","year":"2015","journal-title":"J Crohn\u2019s Colitis"},{"key":"pone.0235142.ref018","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.cgh.2013.03.034","article-title":"Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation","volume":"12","author":"MD Kappelman","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"pone.0235142.ref019","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.crohns.2011.04.013","article-title":"Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study","volume":"5","author":"KH Katsanos","year":"2011","journal-title":"J Crohn\u2019s Colitis"},{"key":"pone.0235142.ref020","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1097\/MIB.0000000000000963","article-title":"Crohn's disease is associated with the risk for thyroid cancer","volume":"22","author":"V Wadhwa","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0235142.ref021","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10350-006-0848-z","article-title":"The risk of cancer in patients with Crohn's disease","volume":"50","author":"AC von Roon","year":"2007","journal-title":"Dis Colon Rectum"},{"key":"pone.0235142.ref022","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: A population-based study","volume":"91","author":"CN Bernstein","year":"2001","journal-title":"Cancer"},{"key":"pone.0235142.ref023","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12957-018-1485-4","article-title":"Assessment of thyroid cancer risk in more than 334,000 patients with inflammatory bowel disease: a case-control study and a meta-analysis","volume":"16","author":"L Cao","year":"2018","journal-title":"World J Surg Oncol"},{"key":"pone.0235142.ref024","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2012.04.016","article-title":"Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years","volume":"143","author":"T Jess","year":"2012","journal-title":"Gastroenterology"},{"key":"pone.0235142.ref025","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"JA Eaden","year":"2001","journal-title":"Gut"},{"key":"pone.0235142.ref026","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1158\/1940-6207.CAPR-16-0124","article-title":"Colorectal cancer and dysplasia in inflammatory bowel disease: a review of disease epidemiology, pathophysiology and management","volume":"9","author":"PS Dulai","year":"2016","journal-title":"Cancer Prev Res"},{"key":"pone.0235142.ref027","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1053\/j.gastro.2010.02.007","article-title":"Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males","volume":"138","author":"S S\u00f6derlund","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"pone.0235142.ref028","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","article-title":"Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies","volume":"25","author":"BM Fung","year":"2019","journal-title":"WJG"},{"key":"pone.0235142.ref029","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.clcc.2017.06.009","article-title":"Intestinal and extraintestinal cancers associated with inflammatory bowel disease","volume":"17","author":"M Chang","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"pone.0235142.ref030","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/ecco-jcc\/jjx035","article-title":"Anal Neoplasia in Inflammatory Bowel Disease: Classification Proposal, Epidemiology, Carcinogenesis, and Risk Management Perspectives","volume":"11","author":"A Wisniewski","year":"2017","journal-title":"J Crohns Colitis"},{"key":"pone.0235142.ref031","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/ajg.2013.249","article-title":"Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: A danish population-based cohort study","volume":"108","author":"T Jess","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"pone.0235142.ref032","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1136\/gutjnl-2013-305300","article-title":"The management of immunosuppression in patients with inflammatory bowel disease and cancer","volume":"62","author":"O Bernheim","year":"2013","journal-title":"Gut"},{"key":"pone.0235142.ref033","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","article-title":"Risk of Lymphoma Associated With Combination Anti\u2013Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis","volume":"7","author":"CA Siegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"pone.0235142.ref034","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.gastro.2012.05.004","article-title":"Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease","volume":"143","author":"MD Long","year":"2012","journal-title":"Gastroenterology"},{"issue":"6","key":"pone.0235142.ref035","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ibd.21484","article-title":"Non-Melanoma Skin Cancer in Inflammatory Bowel Disease","volume":"17","author":"MD Long","year":"2011","journal-title":"A Review. Inflamm Bowel Dis"},{"issue":"11","key":"pone.0235142.ref036","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ecco-jcc\/jjv141","article-title":"European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies","volume":"9","author":"V Annese","year":"2015","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"pone.0235142.ref037","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1136\/gutjnl-2011-301095","article-title":"Increased risk of inflammatory bowel disease in women with endometriosis: A nationwide Danish cohort study","volume":"61","author":"T Jess","year":"2012","journal-title":"Gut"},{"key":"pone.0235142.ref038","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/ibd\/izx062","article-title":"Neoplasia and precursor lesions of the female genital tract in IBD: Epidemiology, role of immunosuppressants, and clinical implications","volume":"24","author":"HMJL Hazenberg","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"pone.0235142.ref039","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of azathioprine and the risk of cancer in inflammatory bowel disease","volume":"177","author":"B Pasternak","year":"2013","journal-title":"Am J Epidemiol"},{"key":"pone.0235142.ref040","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5187061","article-title":"Concomitant thyroid disorders and inflammatory bowel disease: A literature review","volume":"2016","author":"T Shizuma","year":"2016","journal-title":"Biomed Res Int"},{"key":"pone.0235142.ref041","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canep.2016.01.011","article-title":"Cancer among patients with type 2 diabetes mellitus: A population-based cohort study in northeastern Italy","volume":"41","author":"A Gini","year":"2016","journal-title":"Cancer Epidemiology"},{"issue":"4","key":"pone.0235142.ref042","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10072-018-3273-x","article-title":"The epidemiology of Parkinson\u2019s disease in the Italian region Friuli Venezia Giulia: a population-based study with administrative data","volume":"39","author":"F Valent","year":"2018","journal-title":"Neurol Sci"},{"issue":"1","key":"pone.0235142.ref043","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12882-019-1283-4","article-title":"Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy","volume":"20","author":"M Taborelli","year":"2019","journal-title":"BMC Nephrol"},{"issue":"4","key":"pone.0235142.ref044","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/ibd.20021","article-title":"Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.","volume":"13","author":"LJ Herrinton","year":"2007","journal-title":"Inflammatory Bowel Diseases"},{"issue":"9","key":"pone.0235142.ref045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.dld.2014.04.014","article-title":"Occurrence of inflammatory bowel disease in central Italy: A study based on health information systems","volume":"46","author":"R Di Domenicantonio","year":"2014","journal-title":"Digestive and Liver Disease"},{"key":"pone.0235142.ref046","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2147\/CLEP.S151339","article-title":"Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study","volume":"10","author":"MY Friedman","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"3","key":"pone.0235142.ref047","first-page":"15","article-title":"Stima della prevalenza di diabete basata su dati sanitari correnti mediante un algoritmo comune in differenti aree italiane","volume":"32","author":"R Gnavi","year":"2008","journal-title":"Epidemiol Prev"},{"issue":"1","key":"pone.0235142.ref048","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.dld.2017.09.120","article-title":"A model of an inflammatory bowel disease population-based registry: The Forl\u00ec experience (1993\u20132013)","volume":"50","author":"D Valpiani","year":"2018","journal-title":"Dig Liver Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T18:22:37Z","timestamp":1592936557000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235142"}},"subtitle":[],"editor":[{"given":"Jeffrey S.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":48,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235142","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,23]]}}}